G. Virginia Upton

779 total citations
22 papers, 562 citations indexed

About

G. Virginia Upton is a scholar working on Endocrinology, Diabetes and Metabolism, Behavioral Neuroscience and Public Health, Environmental and Occupational Health. According to data from OpenAlex, G. Virginia Upton has authored 22 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Behavioral Neuroscience and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in G. Virginia Upton's work include Stress Responses and Cortisol (5 papers), Pituitary Gland Disorders and Treatments (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). G. Virginia Upton is often cited by papers focused on Stress Responses and Cortisol (5 papers), Pituitary Gland Disorders and Treatments (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). G. Virginia Upton collaborates with scholars based in United States, Canada and Netherlands. G. Virginia Upton's co-authors include Thomas Amatruda, Philip K. Bondy, Edward E. Wallach, Dorothy T. Krieger, Armen H. Tashjian, J.C. Birkenhäger, Dorothy R. Hollingsworth, Saul Lande, Aaron B. Lerner and Richard L. Rudolph and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

G. Virginia Upton

21 papers receiving 483 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
G. Virginia Upton 269 83 74 72 65 22 562
Nasrin Azad 310 1.2× 83 1.0× 27 0.4× 24 0.3× 113 1.7× 26 758
P. Bouloux 111 0.4× 65 0.8× 24 0.3× 77 1.1× 48 0.7× 17 471
S Zgliczyński 501 1.9× 48 0.6× 93 1.3× 37 0.5× 102 1.6× 61 759
H. Brauman 226 0.8× 158 1.9× 44 0.6× 15 0.2× 63 1.0× 41 646
Johannes D. Veldhuis 359 1.3× 51 0.6× 14 0.2× 51 0.7× 98 1.5× 20 671
A. E. Jones 462 1.7× 86 1.0× 16 0.2× 65 0.9× 238 3.7× 29 922
A. Barbarino 640 2.4× 148 1.8× 29 0.4× 88 1.2× 140 2.2× 62 1.0k
F. W. SELBY 512 1.9× 54 0.7× 12 0.2× 55 0.8× 141 2.2× 8 944
Claude Robyn 586 2.2× 52 0.6× 11 0.1× 60 0.8× 139 2.1× 41 961
Y Yaoi 335 1.2× 73 0.9× 27 0.4× 30 0.4× 66 1.0× 35 676

Countries citing papers authored by G. Virginia Upton

Since Specialization
Citations

This map shows the geographic impact of G. Virginia Upton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Virginia Upton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Virginia Upton more than expected).

Fields of papers citing papers by G. Virginia Upton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Virginia Upton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Virginia Upton. The network helps show where G. Virginia Upton may publish in the future.

Co-authorship network of co-authors of G. Virginia Upton

This figure shows the co-authorship network connecting the top 25 collaborators of G. Virginia Upton. A scholar is included among the top collaborators of G. Virginia Upton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Virginia Upton. G. Virginia Upton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freeman, Ellen W., et al.. (2002). Venlafaxine in the Treatment of Premenstrual Dysphoric Disorder. Obstetrical & Gynecological Survey. 57(7). 442–444. 7 indexed citations
2.
Freeman, Ellen W., et al.. (2001). Venlafaxine in the Treatment of Premenstrual Dysphoric Disorder. Obstetrics and Gynecology. 98(5, Part 1). 737–744. 13 indexed citations
3.
Khan, Arifulla, G. Virginia Upton, Richard L. Rudolph, Richard Entsuah, & Steven M. Leventer. (1998). The Use of Venlafaxine in the Treatment of Major Depression and Major Depression Associated With Anxiety. Journal of Clinical Psychopharmacology. 18(1). 19–25. 66 indexed citations
4.
Upton, G. Virginia, et al.. (1992). Contraception for the Transitional Years of Women Older than 40 Years of Age. Clinical Obstetrics & Gynecology. 35(4). 855–864. 4 indexed citations
5.
Wallach, Edward E. & G. Virginia Upton. (1990). Lipids, cardiovascular disease, and oral contraceptives: a practical perspective. Fertility and Sterility. 53(1). 1–12. 33 indexed citations
6.
Upton, G. Virginia. (1987). Contraception for the Perimenopausal Patient. Obstetrics and Gynecology Clinics of North America. 14(1). 207–227. 4 indexed citations
7.
Upton, G. Virginia. (1980). The Physiology of the Perimenopausal Years: A Minireview. International Journal of Gynecology & Obstetrics. 17(6). 531–545. 5 indexed citations
8.
Birkenhäger, J.C., et al.. (1976). MEDULLARY THYROID CARCINOMA: ECTOPIC PRODUCTION OF PEPTIDES WITH ACTH-LIKE, CORTICOTROPHIN RELEASING FACTOR-LIKE AND PROLACTIN PRODUCTION-STIMULATING ACTIVITIES. European Journal of Endocrinology. 83(2). 280–292. 72 indexed citations
9.
Corbin, A., Craig W. Beattie, & G. Virginia Upton. (1975). Effect of pimozide, a dopaminergic blocking agent, on hypothalamic luteinizing hormone releasing hormone activity in hypophysectomized rats. Cellular and Molecular Life Sciences. 31(5). 613–614. 1 indexed citations
10.
Mabry, C. Charlton, Dorothy R. Hollingsworth, G. Virginia Upton, & Alan Corbin. (1973). Pituitary-hypothalamic dysfunction in generalized lipodystrophy. The Journal of Pediatrics. 82(4). 625–633. 25 indexed citations
11.
Corbin, A. & G. Virginia Upton. (1973). Effect of dopaminergic blocking agents on plasma luteinizing hormone releasing hormone activity in hypophysectomized rats. Cellular and Molecular Life Sciences. 29(12). 1552–1553. 7 indexed citations
12.
Corbin, A. & G. Virginia Upton. (1973). Effect of synthetic luteinizing hormone releasing hormone on pituitary and serum levels of luteinizing hormone of intact and median eminence lesioned male rats. Cellular and Molecular Life Sciences. 29(8). 1025–1026. 1 indexed citations
13.
Saffran, Murray, et al.. (1972). Pressinoic acid: A peptide with potent corticotrophin-releasing activity. Biochemical and Biophysical Research Communications. 49(3). 748–751. 8 indexed citations
14.
Upton, G. Virginia & Thomas Amatruda. (1971). Evidence for the Presence of Tumor Peptides with Corticotropin-Releasing-Factor-like Activity in the Ectopic ACTH Syndrome. New England Journal of Medicine. 285(8). 419–424. 128 indexed citations
15.
Upton, G. Virginia, Dorothy R. Hollingsworth, Saul Lande, Aaron B. Lerner, & Thomas Amatruda. (1970). Comparison of Purified Human and Porcine ACTH in Man1. The Journal of Clinical Endocrinology & Metabolism. 30(2). 190–195. 8 indexed citations
16.
Upton, G. Virginia, Aaron B. Lerner, & Saul Lande. (1966). Pituitary Peptides. Journal of Biological Chemistry. 241(23). 5585–5589. 14 indexed citations
17.
Lande, Saul, Aaron B. Lerner, & G. Virginia Upton. (1965). Pituitary Peptides. Journal of Biological Chemistry. 240(11). 4259–4263. 21 indexed citations
18.
Amatruda, Thomas, et al.. (1960). A STUDY OF THE MECHANISM OF THE STEROID WITHDRAWAL SYNDROME. EVIDENCE FOR INTEGRITY OF THE HYPOTHALAMICPITUITARY-ADRENAL SYSTEM*. The Journal of Clinical Endocrinology & Metabolism. 20(3). 339–354. 50 indexed citations
19.
Upton, G. Virginia & Philip K. Bondy. (1958). The binding of cortisol by plasma protein. Archives of Biochemistry and Biophysics. 78(1). 197–205. 18 indexed citations
20.
Bondy, Philip K., G. Virginia Upton, & Grace E. Pickford. (1957). Demonstration of Cortisol in Fish Blood. Nature. 179(4574). 1354–1355. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nasrin Azad Breakdown of academic impact, for papers by P. Bouloux Breakdown of academic impact, for papers by S Zgliczyński Breakdown of academic impact, for papers by H. Brauman Breakdown of academic impact, for papers by Johannes D. Veldhuis Breakdown of academic impact, for papers by A. E. Jones Breakdown of academic impact, for papers by A. Barbarino Breakdown of academic impact, for papers by F. W. SELBY Breakdown of academic impact, for papers by Claude Robyn Breakdown of academic impact, for papers by Y Yaoi
Rankless by CCL
2026